1
|
Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN, Kwiatkowski JL, Roach ES, Kirkham FJ, Casella JF, DeBaun MR. Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction. J Pediatr 2014; 164:1175-1180.e1. [PMID: 24529619 PMCID: PMC4078657 DOI: 10.1016/j.jpeds.2014.01.001] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/21/2013] [Revised: 10/31/2013] [Accepted: 01/02/2014] [Indexed: 10/25/2022]
Abstract
OBJECTIVE To identify risk factors for headache and migraine in children with sickle cell disease and test the hypothesis that either or both are independently associated with silent cerebral infarcts. STUDY DESIGN In this cross-sectional study, we evaluated the health history, laboratory values, and brain magnetic resonance imaging findings of participants with sickle cell disease (hemoglobinSS or hemoglobinSβ°-thalassemia) with no history of overt stroke or seizures. Participants characterized headache severity and quality. Migraine was defined by International Headache Society criteria modified for increased sensitivity in children. Neuroradiology and neurology committees adjudicated the presence of silent cerebral infarction by review of magnetic resonance imaging and standardized examination by pediatric neurologists. RESULTS The cohort included 872 children (51.1% males), ranging in age from 5 to 15 years (mean age, 9.1 years). Of these children, 317 (36.4%) reported recurrent headaches, and 132 (15.1%) reported migraines. In multivariable logistic regression analyses, both were associated with lower steady-state hemoglobin (P = .01 for headaches; P < .01 for migraines) and higher pain rate (P < .01 for headaches; P < .01 for migraines), defined as the number of admissions requiring opioids in the previous 3 years. The presence of silent cerebral infarction was not associated with recurrent headaches or migraines. Only 1.9% (6 of 317) of children with recurrent headaches received medication for headache prophylaxis. CONCLUSION Recurrent headaches and migraines are common and undertreated in children with sickle cell disease. Low hemoglobin levels and high pain rates are associated with recurrent headaches and migraines; whereas, silent cerebral infarction is not.
Collapse
Affiliation(s)
| | - Michael J Noetzel
- St. Louis Children’s Hospital and Washington University School of Medicine
| | | | - Charles T Quinn
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Deborah G Hirtz
- National Institutes of Health, National Institute of Neurological Disorders and Stroke, Bethesda, MD
| | - Rebecca N Ichord
- Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, PA
| | - Janet L Kwiatkowski
- Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, PA
| | - E Steven Roach
- Division of Child Neurology, Ohio State College of Medicine
| | | | - James F Casella
- Department of Pediatrics, Division of Pediatric Hematology, the Johns Hopkins University School of Medicine, Baltimore, MD
| | - Michael R DeBaun
- Department of Pediatrics Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease, Vanderbilt University School of Medicine, Nashville, TN.
| |
Collapse
|
2
|
Winchell AM, Taylor BA, Song R, Loeffler RB, Grundlehner P, Hankins JS, Wang WC, Ogg RJ, Hillenbrand CM, Helton KJ. Evaluation of SWI in children with sickle cell disease. AJNR Am J Neuroradiol 2014; 35:1016-21. [PMID: 24263696 DOI: 10.3174/ajnr.a3794] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
BACKGROUND AND PURPOSE SWI is a powerful tool for imaging of the cerebral venous system. The SWI venous contrast is affected by blood flow, which may be altered in sickle cell disease. In this study, we characterized SWI venous contrast in patients with sickle cell disease and healthy control participants and examined the relationships among SWI venous contrast, and hematologic variables in the group with sickle cell disease. MATERIALS AND METHODS A retrospective review of MR imaging and hematologic variables from 21 patients with sickle cell disease and age- and sex-matched healthy control participants was performed. A Frangi vesselness filter was used to quantify the attenuation of visible veins from the SWI. The normalized visible venous volume was calculated for quantitative analysis of venous vessel conspicuity. RESULTS The normalized visible venous volume was significantly lower in the group with sickle cell disease vs the control group (P < .001). Normalized visible venous volume was not associated with hemoglobin, percent hemoglobin F, percent hemoglobin S, absolute reticulocyte count, or white blood cell count. A hypointense arterial signal on SWI was observed in 18 of the 21 patients with sickle cell disease and none of the 21 healthy control participants. CONCLUSIONS This study demonstrates the variable and significantly lower normalized visible venous volume in patients with sickle cell disease compared with healthy control participants. Decreased venous contrast in sickle cell disease may reflect abnormal cerebral blood flow, volume, velocity, or oxygenation. Quantitative analysis of SWI contrast may be useful for investigation of cerebrovascular pathology in patients with sickle cell disease, and as a tool to monitor therapies. However, future studies are needed to elucidate physiologic mechanisms of decreased venous conspicuity in sickle cell disease.
Collapse
Affiliation(s)
- A M Winchell
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| | - B A Taylor
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| | - R Song
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| | - R B Loeffler
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| | - P Grundlehner
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| | - J S Hankins
- Hematology (J.S.H., W.C.W.), St. Jude Children's Research Hospital, Memphis, Tennessee
| | - W C Wang
- Hematology (J.S.H., W.C.W.), St. Jude Children's Research Hospital, Memphis, Tennessee
| | - R J Ogg
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| | - C M Hillenbrand
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| | - K J Helton
- From the Departments of Radiological Sciences (A.M.W., B.A.T., R.S., R.B.L., P.G., R.J.O., C.M.H., K.J.H.)
| |
Collapse
|
3
|
Mallick AA, O’Callaghan FJK. Risk factors and treatment outcomes of childhood stroke. Expert Rev Neurother 2014; 10:1331-46. [DOI: 10.1586/ern.10.106] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
4
|
Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease. Blood 2012; 120:3891-7. [PMID: 22948048 DOI: 10.1182/blood-2012-01-406314] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We hypothesized that the silent cerebral infarcts (SCI), which affect up to 40% of children with sickle cell disease (SCD), could occur in the setting of acute anemic events. In a prospective observational study of children with and without SCD hospitalized for an illness associated with acute anemia, we identified acute silent cerebral ischemic events (ASCIE) in 4 (18.2%) of 22 with SCD and in 2 (6.7%) of 30 without SCD, using diffusion-weighted magnetic resonance imaging. Children with ASCIE had lower hemoglobin concentration than those without (median 3.1 vs 4.4 g/dL, P = .003). The unique temporal features of stroke on diffusion-weighted magnetic resonance imaging permit estimation of incidence rates for ASCIE of 421 (95% confidence interval, 155-920) per 100 patient-years during acute anemic events for all patients. For children with SCD, the estimated incidence was 663 (95% confidence interval, 182-1707) which is much higher than previously reported. Acute anemic events are common in children with SCD and prevalence could partially account for the high SCI. Some ASCIE (1 of 4 in our study) may be reversible. Alterations in management may be warranted for children with severe anemia to identify unrecognized ischemic brain injury that may have permanent neurocognitive sequelae.
Collapse
|
5
|
L'Esperance VS, Cox SE, Simpson D, Gill C, Makani J, Soka D, Mgaya J, Kirkham FJ, Clough GF. Peripheral vascular response to inspiratory breath hold in paediatric homozygous sickle cell disease. Exp Physiol 2012; 98:49-56. [PMID: 22660812 PMCID: PMC4463767 DOI: 10.1113/expphysiol.2011.064055] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
New Findings • What is the central question of this study? Autonomic nervous dysfunction is implicated in complications of sickle cell anaemia (SCA). In healthy adults, a deep inspiratory breath hold (IBH) elicits rapid transient SNS- mediated vasoconstriction detectable using Laser Doppler Flux (LDF) assessment of the finger-tip cutaneous micovasculature. • What is the main finding and its importance? We demonstrate significantly increased resting peripheral blood flow and sympathetic activity in African children with SCA compared to sibling controls and increased sympathetic stimulation in response to vasoprovocation with DIG. This study is the first to observe an inverse association between resting peripheral blood flow and haemoglobin oxygen saturation (SpO2). These phenomena may be an adaptive response to the hypoxic exposure in SCA. There is increasing evidence that autonomic dysfunction in adults with homozygous sickle cell (haemoglobin SS) disease is associated with enhanced autonomic nervous system-mediated control of microvascular perfusion. However, it is unclear whether such differences are detectable in children with SS disease. We studied 65 children with SS disease [38 boys; median age 7.2 (interquartile range 5.1–10.6) years] and 20 control children without symptoms of SS disease [8 boys; 8.7 (5.5–10.8) years] and recorded mean arterial blood pressure (ABP) and daytime haemoglobin oxygen saturation (). Cutaneous blood flux at rest (RBF) and during the sympathetically activated vasoconstrictor response to inspiratory breath hold (IBH) were measured in the finger pulp of the non-dominant hand using laser Doppler fluximetry. Local factors mediating flow motion were assessed by power spectral density analysis of the oscillatory components of the laser Doppler signal. The RBF measured across the two study groups was negatively associated with age (r=−0.25, P < 0.0001), ABP (r=−0.27, P= 0.02) and daytime (r=−0.30, P= 0.005). Children with SS disease had a higher RBF (P= 0.005) and enhanced vasoconstrictor response to IBH (P= 0.002) compared with control children. In children with SS disease, higher RBF was associated with an increase in the sympathetic interval (r=−0.28, P= 0.022). The SS disease status, daytime and age explained 22% of the variance in vasoconstrictor response to IBH (P < 0.0001). Our findings suggest that blood flow and blood flow responses in the skin of young African children with SS disease differ from those of healthy control children, with increased resting peripheral blood flow and increased sympathetic stimulation from a young age in SS disease. They further suggest that the laser Doppler flowmetry technique with inspiratory breath hold manoeuvre appears to be robust for use in young children with SS disease, to explore interactions between , ABP and autonomic function with clinical complications, e.g. skin ulceration.
Collapse
Affiliation(s)
- Veline S L'Esperance
- Vascular Research Group, Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Treatment of “Other” Stroke Etiologies. Stroke 2011. [DOI: 10.1016/b978-1-4160-5478-8.10054-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
7
|
Abstract
In recent years, there has been increasing recognition of the impact of childhood stroke and interest in the role of drugs in the acute, chronic, and prophylactic management of this condition. Most treatment strategies are based on studies in adults with stroke, and the relative infrequency of stroke and the heterogeneity of etiologies in childhood compared with adults present significant challenges in study design for childhood stroke studies. The presence of thrombophilia has been associated with stroke in children, strengthening the concept that antithrombotic, antiplatelet, and even thrombolytic agents have a role in stroke treatment and prevention. There are several potential roles for drugs in the treatment of childhood stroke including hyperacute therapy, antithrombotic medication, antiplatelet medication, and disease-specific medications. Herein, we review the use and rationale of these medications in childhood arterial ischemic stroke.
Collapse
|
8
|
Lopez-Vicente M, Ortega-Gutierrez S, Amlie-Lefond C, Torbey MT. Diagnosis and management of pediatric arterial ischemic stroke. J Stroke Cerebrovasc Dis 2010; 19:175-183. [PMID: 20434043 DOI: 10.1016/j.jstrokecerebrovasdis.2009.03.013] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2008] [Revised: 03/13/2009] [Accepted: 03/26/2009] [Indexed: 01/07/2023] Open
Abstract
Pediatric stroke is among the top 10 causes of death in children and an important cause of chronic morbidity, with an incidence of 3.3/100,000 children/year. Risk factors associated with stroke in children include cardiac diseases, hematologic and vascular disorders, and infection. Clinical presentation varies depending on age, underlying cause, and stroke location. Antithrombotics and anticoagulants are used in the treatment of pediatric stroke; however, there are no established guidelines for the use of these agents in children. In this article we review the cause, pathophysiology, clinical presentation, diagnosis, acute management, secondary prevention, and outcome of children with stroke. The approach to patients with sickle cell disease and Moyamoya disease is also discussed. Up to date studies to determine the optimal acute treatment of childhood stroke and secondary prevention and risk factor modification are critically needed.
Collapse
Affiliation(s)
- Marta Lopez-Vicente
- Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee.
| | - Santiago Ortega-Gutierrez
- Department of Neurology, Medical College of Wisconsin, Milwaukee; Department of Medicine, Medical College of Wisconsin, Milwaukee
| | | | - Michel T Torbey
- Department of Neurology, Medical College of Wisconsin, Milwaukee; Department of Neurosurgery, Medical College of Wisconsin, Milwaukee
| |
Collapse
|
9
|
Mousa SA, Abbdulkareem Al Momen, Faisal Al Sayegh, Soad Al Jaouni, Nasrullah Z, Hussein Al Saeed, Alabdullatif A, Mohamad Al Sayegh, Hazaa Al Zahrani, Hegazi M, Amin Al Mohamadi, Alsulaiman A, Omer A, Salam Al Kindi, Tarawa A, Fahad Al Othman, Qari M. Review: Management of Painful Vaso-Occlusive Crisis of Sickle-Cell Anemia: Consensus Opinion. Clin Appl Thromb Hemost 2010; 16:365-76. [PMID: 20530056 DOI: 10.1177/1076029609352661] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Sickle-cell disease (SCD) is a wide-spread inherited hemolytic anemia that is due to a point mutation, leading to the substitution of valine for glutamic acid, causing a spectrum of clinical manifestations in addition to hemolysis and anemia. Acute painful crisis is a common sequela that can cause significant morbidity and negatively impact the patient’s quality of life. Remarkable improvements in the understanding of the pathogenesis of this clinical syndrome and the role of cell adhesion, inflammation, and coagulation in acute painful crisis have led to changes in the management of pain. Due to the endemic nature of SCD in various parts of the Middle East, a group of physicians and scientists from the United States and Middle East recently met to draw up a set of suggested guidelines for the management of acute painful crisis that are reflective of local and international experience. This review brings together a detailed etiology, the pathophysiology, and clinical presentation of SCD, including the differential diagnoses of pain associated with the disease, with evidence-based recommendations for pain management and the potential impact of low-molecular-weight heparin (LMWH), from the perspective of physicians and scientists with long-term experience in the management of a large number of patients with SCD.
Collapse
Affiliation(s)
- Shaker A. Mousa
- Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, New York
| | - Abbdulkareem Al Momen
- King Saud University College of Medicine, Department of Medicine, Hematology Oncology Division, Riyadh, Saudi Arabia
| | | | - Soad Al Jaouni
- King Saud University College of Medicine, Department of Medicine, Hematology Oncology Division, Riyadh, Saudi Arabia
| | | | | | | | | | | | - Maha Hegazi
- King Saud University College of Medicine, Department of Medicine, Hematology Oncology Division, Riyadh, Saudi Arabia
| | - Amin Al Mohamadi
- King Saud University College of Medicine, Department of Medicine, Hematology Oncology Division, Riyadh, Saudi Arabia
| | - A. Alsulaiman
- King Faisal Specialist Hospital, Riyadh, Saudi Arabia
| | - Awad Omer
- Security Forces Hospital, Riyadh, Saudi Arabia
| | | | - Ahamd Tarawa
- Madina Maternity and Children's Hospital, Madina, Saudi Arabia
| | | | - Mohammad Qari
- College of Medicine King Abdul-Aziz University, Jeddah, Saudi Arabia
| |
Collapse
|
10
|
Dowling MM, Quinn CT, Rogers ZR, Buchanan GR. Acute silent cerebral infarction in children with sickle cell anemia. Pediatr Blood Cancer 2010; 54:461-4. [PMID: 19813251 PMCID: PMC2807470 DOI: 10.1002/pbc.22242] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Silent cerebral infarctions (SCI) occur in up to 35% of children with sickle cell anemia (HbSS) but are rarely recognized during the initial 10-14 days when diffusion weighted magnetic resonance imaging (MRI) can differentiate acute infarctions from remote events. We report acute SCI in seven children with HbSS who had areas of restricted diffusion on MRI without persistent focal neurologic deficits. Four had acute SCI identified following acute anemic events. Our observations suggest that SCI are detectible in the acute phase, present with subtle neurologic symptoms, result in permanent neurologic injury, and may be caused by acute anemic events.
Collapse
Affiliation(s)
- Michael M. Dowling
- Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,The Southwestern Comprehensive Sickle Cell Center, Children’s Medical Center Dallas, Dallas, Texas
| | - Charles T. Quinn
- Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,The Southwestern Comprehensive Sickle Cell Center, Children’s Medical Center Dallas, Dallas, Texas
| | - Zora R. Rogers
- Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,The Southwestern Comprehensive Sickle Cell Center, Children’s Medical Center Dallas, Dallas, Texas
| | - George R. Buchanan
- Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,The Southwestern Comprehensive Sickle Cell Center, Children’s Medical Center Dallas, Dallas, Texas
| |
Collapse
|
11
|
Abstract
Sickle cell disease (SCD) is a wide-spread inherited hemolytic anemia that is due to a point mutation leading to a valine/glutamic acid substitution in the beta-globin chain, causing a spectrum of clinical manifestations in addition to hemolysis and anemia. Acute painful crisis is a common sequela that can cause significant morbidity and negatively impact the patient's quality of life. Remarkable improvements in our understanding of the pathogenesis of this clinical syndrome and the role of cell adhesion, inflammation, and coagulation in acute painful crisis have led to changes in the management of pain. Due to the endemic nature of SCD in various parts of the Middle East, a group of physicians and scientists from the United States and Middle East recently met to draw up a set of suggested guidelines for the management of acute painful crisis that are reflective of local and international experience. This chapter brings together a detailed etiology, pathophysiology, and clinical presentation of SCD, including the differential diagnoses of pain associated with the disease, with evidence-based recommendations for pain management and the potential impact of low-molecular weight heparin (LMWH), from the perspective of physicians and scientists with long-term experience in the management of a large number of SCD patients.
Collapse
Affiliation(s)
- Shaker A Mousa
- Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA
| | | |
Collapse
|
12
|
Abstract
PURPOSE Stroke and subclinical "silent infarcts" are major causes of morbidity in children with Sickle Cell Disease (SCD). Ischemic strokes are more common in younger children while hemorrhagic strokes are more frequent in adults. The goal of neuroimaging in acute stroke is to document whether the stroke is ischemic or hemorrhagic, to assess the extent of parenchymal abnormalities and to determine the presence of other cerebrovascular lesions. Computed Tomography (CT) is the primary modality for the assessment of acute stroke patients because of its 24/7 availability and ability to exclude hemorrhagic causes. Magnetic resonance imaging (MRI) and MR angiography (MRA) are recommended to determine precisely extent of infarction and detect cerebrovascular abnormalities. The goal of neuroimaging in patients with hemorrhagic stroke is to identify an arteriovenous malformation or aneurysm(s) amenable to surgery or catheter intervention.The risk of first stroke is very high in asymptomatic children with intracranial arterial mean velocities over 200 cm/s on transcranial Doppler (TCD) examination. The risk can be substantially reduced if chronic blood transfusions are timely implemented. Large cerebral vessel disease detected by TCD can be confirmed or excluded by MRI/MRA. Those with evidence of parenchymal and/or cerebrovascular lesions should be followed by preventive therapy. In patients with neurologic symptoms and negative MRI/MRA findings Positron Emission Tomography or single photon emission CT is recommended. There are no specific neuroimaging findings that suggest that blood transfusions can be safely halted in children with SCD.
Collapse
|
13
|
Affiliation(s)
- Steven G. Pavlakis
- From the Maimonides Infants and Children’s Hospital and Mount Sinai School of Medicine, Brooklyn, NY
| | - Kim Levinson
- From the Maimonides Infants and Children’s Hospital and Mount Sinai School of Medicine, Brooklyn, NY
| |
Collapse
|
14
|
|
15
|
|
16
|
Amlie-Lefond C, Sébire G, Fullerton HJ. Recent developments in childhood arterial ischaemic stroke. Lancet Neurol 2008; 7:425-35. [DOI: 10.1016/s1474-4422(08)70086-3] [Citation(s) in RCA: 100] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Shet AS, Hoffmann TJ, Jirouskova M, Janczak CA, Stevens JRM, Adamson A, Mohandas N, Manci EA, Cynober T, Coller BS. Morphological and functional platelet abnormalities in Berkeley sickle cell mice. Blood Cells Mol Dis 2008; 41:109-18. [PMID: 18374611 DOI: 10.1016/j.bcmd.2008.01.008] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2008] [Accepted: 01/24/2008] [Indexed: 11/27/2022]
Abstract
Berkeley sickle cell mice are used as animal models of human sickle cell disease but there are no reports of platelet studies in this model. Since humans with sickle cell disease have platelet abnormalities, we studied platelet morphology and function in Berkeley mice (SS). We observed elevated mean platelet forward angle light scatter (FSC) values (an indirect measure of platelet volume) in SS compared to wild type (WT) (37+/-3.2 vs. 27+/-1.4, mean+/-SD; p<0.001), in association with moderate thrombocytopenia (505+/-49 x 10(3)/microl vs. 1151+/-162 x 10(3)/microl; p<0.001). Despite having marked splenomegaly, SS mice had elevated levels of Howell-Jolly bodies and "pocked" erythrocytes (p<0.001 for both) suggesting splenic dysfunction. SS mice also had elevated numbers of thiazole orange positive platelets (5+/-1% vs. 1+/-1%; p<0.001), normal to low plasma thrombopoietin levels, normal plasma glycocalicin levels, normal levels of platelet recovery, and near normal platelet life spans. Platelets from SS mice bound more fibrinogen and antibody to P-selectin following activation with a threshold concentration of a protease activated receptor (PAR)-4 peptide compared to WT mice. Enlarged platelets are associated with a predisposition to arterial thrombosis in humans and some humans with SCD have been reported to have large platelets. Thus, additional studies are needed to assess whether large platelets contribute either to pulmonary hypertension or the large vessel arterial occlusion that produces stroke in some children with sickle cell disease.
Collapse
Affiliation(s)
- Arun S Shet
- The Laboratory of Blood and Vascular Biology, Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Abstract
The environment has profound influences on human health. Environment is the combination of natural (physical, chemical, biological) and cultural (sociological) conditions in which living organisms, man in particular, develop. Adaptation is the human physiological response to external factors including mechanisms such as circadian rhythms (sleep and wakefulness), biorhythms, thermoregulation, and others to adjust to changes in natural conditions (night and day, cosmic rhythms, climatic changes). Man remains vulnerable due to a number of factors: genetic, physiological, age, sex, impaired reparative or protective mechanisms, or acquired factors (risky behaviors and lifestyle, nutritional habits). Hazard is the potential of a particular factor to have a negative impact on health. Risk is the probability of that hazard occurring; it defines and measures the predictability of that hazard. A number of environmental factors have a profound influence on the pathogenesis of neurological disorders. Environmental neurology follows the classical diagnostic precepts: from symptom to syndrome in the search for etiology and individualized treatment of the patient. It also utilizes principles of epidemiology and public health, toxicology and occupational medicine; i.e., an approach by "milieu" and by specific factors or "agents." Environmental neurology offers a promising new field of practice and research.
Collapse
|
19
|
|
20
|
Kirkham FJ. Therapy Insight: stroke risk and its management in patients with sickle cell disease. ACTA ACUST UNITED AC 2007; 3:264-78. [PMID: 17479074 DOI: 10.1038/ncpneuro0495] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2006] [Accepted: 03/15/2007] [Indexed: 11/09/2022]
Abstract
Children with sickle cell disease, a chronic hemolytic anemia, present with a wide variety of neurological syndromes, including ischemic and hemorrhagic stroke, transient ischemic attacks, 'soft neurological signs', seizures, headache, coma, visual loss, altered mental status, cognitive difficulties, and covert or 'silent' infarction. Those with ischemic stroke usually have stenosis or occlusion of the distal internal carotid and proximal middle cerebral arteries. Indefinite transfusion prevents recurrence in most patients who have had a stroke, and can prevent first stroke in those with high transcranial Doppler velocities. High white cell count, low hemoglobin and oxyhemoglobin desaturation predict neurological complications. Other risk factors for overt ischemic stroke include hypertension, previous transient ischemic attack, covert infarction and chest crisis. For hemorrhagic stroke, aneurysms are common in adults but not children, who often present with hypertension after transfusion or corticosteroids. Seizures are particularly common in patients with cerebrovascular disease and covert infarction; the latter is also associated with hyposplenism and infrequent pain. Factors associated with cognitive difficulties include thrombocytosis, infarction, large-vessel disease, and perfusion abnormality on neuroimaging. As well as investigating the role of genes and the possibility that hydroxyurea or blood pressure control reduce neurological complications, we should explore the modifiable effects of poor nutrition, chronic infection, hemolysis and oxyhemoglobin desaturation on stroke risk.
Collapse
Affiliation(s)
- Fenella J Kirkham
- Neurosciences Unit, University College London Institute of Child Health, London, UK.
| |
Collapse
|
21
|
Abstract
PURPOSE OF REVIEW Stroke is one of the most devastating complications of sickle cell disease, but current research has led to improved understanding of its pathogenesis and to new approaches in the prevention of both primary and secondary stroke. This review focuses on advances reported in the past 2 years. RECENT FINDINGS New concepts in the pathophysiology of central nervous system events in sickle cell disease have centered around hemolytic anemia and nitric oxide metabolism. Genetic risk factors are now being explored. Major improvement in primary stroke prevention has occurred through transcranial Doppler ultrasonography screening, but utilization of this technique is far from optimal. Hydroxyurea is now being tested as an alternative approach to chronic transfusion for secondary stroke prevention through a multicenter trial. Other studies are addressing the management of silent infarcts and nocturnal hypoxemia. SUMMARY Increased understanding of the etiology and pathogenesis of stroke in sickle cell disease should eventually lead to improved management of all central nervous system complications. Alternative secondary stroke prevention with hydroxyurea may allow patients to avoid dependence on life-long chronic transfusion. Primary stroke prevention through transcranial Doppler ultrasonography screening may ultimately yield a dramatic reduction in the incidence of stroke in sickle cell disease.
Collapse
Affiliation(s)
- Winfred C Wang
- Department of Hematology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
| |
Collapse
|
22
|
Millichap JG. Stroke Prevention Trials in Sickle Cell Anemia. Pediatr Neurol Briefs 2006. [DOI: 10.15844/pedneurbriefs-20-6-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|